p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

FGFR signalling is one of the most prominent pathways involved in cell growth and development as well as cancer progression. FGFR1 amplification occurs in approximately 20% of all squamous cell lung carcinomas (SCC), a predominant subtype of non-small cell lung carcinoma (NSCLC), indicating FGFR as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarczynska, Izabela, Gorska-Arcisz, Monika, Cortez, Alexander Jorge, Kujawa, Katarzyna Aleksandra, Wilk, Agata Małgorzata, Skladanowski, Andrzej Cezary, Stanczak, Aleksandra, Skupinska, Monika, Wieczorek, Maciej, Lisowska, Katarzyna Marta, Sadej, Rafal, Kitowska, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699485/
https://www.ncbi.nlm.nih.gov/pubmed/34943871
http://dx.doi.org/10.3390/cells10123363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699485/
https://www.ncbi.nlm.nih.gov/pubmed/34943871
http://dx.doi.org/10.3390/cells10123363

Ejemplares similares